Sander A. Flaum, Director at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 5,000 shares at $78.66 ($393K) on 2016-11-28, disclosed to the SEC on 2016-11-30.
Open-market sale of $393k EGRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |